Hou W - Search Results

1

IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell.

Shao L, Hou W, Scharping NE, Vendetti FP, Srivastava R, Roy CN, Menk AV, Wang Y, Chauvin JM, Karukonda P, Thorne SH, Hornung V, Zarour HM, Bakkenist CJ, Delgoffe GM, Sarkar SN. Shao L, et al. Among authors: hou w. Cancer Immunol Res. 2019 Aug;7(8):1258-1266. doi: 10.1158/2326-6066.CIR-18-0711. Epub 2019 Jun 25. Cancer Immunol Res. 2019. PMID: 31239318 Free PMC article.

2

Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF.

Hou W, Chen H, Rojas J, Sampath P, Thorne SH. Hou W, et al. Int J Cancer. 2014 Sep 1;135(5):1238-46. doi: 10.1002/ijc.28747. Epub 2014 Feb 18. Int J Cancer. 2014. PMID: 24474587 Free PMC article.

3

Regulating cytokine function enhances safety and activity of genetic cancer therapies.

Chen H, Sampath P, Hou W, Thorne SH. Chen H, et al. Among authors: hou w. Mol Ther. 2013 Jan;21(1):167-74. doi: 10.1038/mt.2012.225. Epub 2012 Nov 13. Mol Ther. 2013. PMID: 23281444 Free PMC article.

4

CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency.

Li F, Sheng Y, Hou W, Sampath P, Byrd D, Thorne S, Zhang Y. Li F, et al. Among authors: hou w. J Immunother Cancer. 2020 Feb;8(1):e000131. doi: 10.1136/jitc-2019-000131. J Immunother Cancer. 2020. PMID: 32098828 Free PMC article.

5

Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy.

Rojas JJ, Sampath P, Hou W, Thorne SH. Rojas JJ, et al. Among authors: hou w. Clin Cancer Res. 2015 Dec 15;21(24):5543-51. doi: 10.1158/1078-0432.CCR-14-2009. Epub 2015 Jul 17. Clin Cancer Res. 2015. PMID: 26187615 Free PMC article.

6

Oncolytic Virus-Mediated Targeting of PGE2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy.

Hou W, Sampath P, Rojas JJ, Thorne SH. Hou W, et al. Cancer Cell. 2016 Jul 11;30(1):108-119. doi: 10.1016/j.ccell.2016.05.012. Epub 2016 Jun 30. Cancer Cell. 2016. PMID: 27374223 Free PMC article.

7

Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effects.

Sampath P, Li J, Hou W, Chen H, Bartlett DL, Thorne SH. Sampath P, et al. Among authors: hou w. Mol Ther. 2013 Mar;21(3):620-8. doi: 10.1038/mt.2012.257. Epub 2012 Dec 11. Mol Ther. 2013. PMID: 23229093 Free PMC article.

8

Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies.

Rojas JJ, Sampath P, Bonilla B, Ashley A, Hou W, Byrd D, Thorne SH. Rojas JJ, et al. Among authors: hou w. Cell Rep. 2016 Apr 12;15(2):264-73. doi: 10.1016/j.celrep.2016.03.017. Epub 2016 Mar 31. Cell Rep. 2016. PMID: 27050526 Free PMC article.

9

In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe.

Zhang S, Shao P, Ling X, Yang L, Hou W, Thorne SH, Beaino W, Anderson CJ, Ding Y, Bai M. Zhang S, et al. Among authors: hou w. Am J Nucl Med Mol Imaging. 2015 Feb 15;5(3):246-58. eCollection 2015. Am J Nucl Med Mol Imaging. 2015. PMID: 26069858 Free PMC article.

10

Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions.

Nakajima EC, Laymon C, Oborski M, Hou W, Wang L, Grandis JR, Ferris RL, Mountz JM, Van Houten B. Nakajima EC, et al. Among authors: hou w. PLoS One. 2014 Aug 15;9(8):e102452. doi: 10.1371/journal.pone.0102452. eCollection 2014. PLoS One. 2014. PMID: 25127378 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,656 results

Search Page

Filters